Industry reports
Editor highlights

Publication dates

data types

Interferon Market and Forecasts, April 2014

You might be interested in: biosimilar, protein, hepatitis c, more »


 
1-10 of about 200 reports for Interferon

The Australian Biopharmaceutical Industry Brief (biopharmaceutical, hepatitis b vaccine, interferon alpha)

  • Industry report
  • January 2012
  • 2 pages
  • by Corporation

... Hepatitis b vaccine and therapeutics such as rhuman growth hormone, rhuman insulin, gcsf and interferon alpha 2b. Scigen has acquired the rights to manufacture, distribute and market biopharmaceutical ...

The Australian Biopharmaceutical Industry Brief (biopharmaceutical, interferon alpha, growth hormone)

  • Industry report
  • January 2012
  • 2 pages
  • by Corporation

... Therapeutics such as rhuman growth hormone, rhuman insulin, gcsf and interferon alpha 2b. For personal use only ______________________________________________________________________ scigen limited arbn 101 ...

Medication Sector Trends in The United States

  • Industry report
  • September 2012
  • 8 pages

... Billion.7 Currently, the world market for ms drugs is $14 billion per year.3 Remarks Among existing therapies, the various interferon formulations and glatiramer acetate (ga) have historically ...

The French Cytokine Sector Brief

  • Industry report
  • October 2012
  • 5 pages

... Production of interferon (ifn) and other cytokines has been suggested to be possible throughout life. Minimum amounts of ifn-a and ifn--y may be produced in localized lymphoid microenvironments on induction ...

Drug and Medication in China : Innovation and Technology Trends

  • Industry report
  • March 2012
  • 30 pages
  • by Corporation

... Efficacy over time and interferon is very expensive next generation rx and dx 1. Ims health 8 next generation for personal use only clinical goals of hbv treatment treatment suppress hbv-dna near ...

Biological Therapy Business Brief

  • Industry report
  • February 2012
  • 8 pages
  • by Corporation

... To forward scatter (x-axis) and side scatter (y-axis). (C) shows the gamma interferon produced from total lymphocytes after stimulation with ppd. The position of the gate was determined in the unstimulated ...

The Canadian Drug and Medication Business Analysis

  • Industry report
  • November 2012
  • 129 pages

... Treatment initiated with pegylated interferon alpha-2b (120mcg) plus ribavirin (500mg bid), as planned lead-in to boceprevir-based treatment. Week 0 hcv rna 5.29 Logs alt 106 hb 144 plts 295 neutrophils 6 ...

Biological Therapy Market in The United Kingdom

  • Industry report
  • April 2012
  • 10 pages

... James interferon and interleukin-10 in children antigens by t-cell-derived gamma antibody to pneumococcal protein regulation of production of mucosal - updated ...

Hepatitis in The United States : Innovation and Technology Trends (hepatitis, liver disease)

  • Industry report
  • September 2013
  • 29 pages

... Direct-acting antivirals protease inhibitors boceprevir (victrelis) telaprevir (incivek) triple therapy- peg-interferon/ribavirin/protease inhibitor for genotype 1, 24-48 weeks svr for genotype 1 ...

Hepatitis C Sector (hepatitis c, liver disease) in The United States

  • Industry report
  • November 2013
  • 23 pages

... Advanced clinical trials testing interferon-free and ribavirin-free treatment regimens, including genotype 1 who should get tested for hcv What group is 5x more likely than other adults to have hcv ...

» Purchase Premium Reports (From $ 400 - $ 9 995)

64 reports for Interferon
Sustained Release Injectables to 2020

Sustained Release Injectables to 2020

  • $ 3 850
  • Industry report
  • January 2014
  • by Greystone Research Associates

The ability to formulate injectable drugs to increase the duration of efficacy for a given dose and simultaneously reduce the dosing frequency addresses several important health care issues. Less frequent ...


» Read our Company Profiles

1 Companies for Interferon

Roche Holding AG

Switzerland

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.